Literature DB >> 22884585

Cortical metabolism in pyruvate dehydrogenase deficiency revealed by ex vivo multiplet (13)C NMR of the adult mouse brain.

Isaac Marin-Valencia1, Levi B Good, Qian Ma, Craig R Malloy, Mulchand S Patel, Juan M Pascual.   

Abstract

The pyruvate dehydrogenase complex (PDC), required for complete glucose oxidation, is essential for brain development. Although PDC deficiency is associated with a severe clinical syndrome, little is known about its effects on either substrate oxidation or synthesis of key metabolites such as glutamate and glutamine. Computational simulations of brain metabolism indicated that a 25% reduction in flux through PDC and a corresponding increase in flux from an alternative source of acetyl-CoA would substantially alter the (13)C NMR spectrum obtained from brain tissue. Therefore, we evaluated metabolism of [1,6-(13)C(2)]glucose (oxidized by both neurons and glia) and [1,2-(13)C(2)]acetate (an energy source that bypasses PDC) in the cerebral cortex of adult mice mildly and selectively deficient in brain PDC activity, a viable model that recapitulates the human disorder. Intravenous infusions were performed in conscious mice and extracts of brain tissue were studied by (13)C NMR. We hypothesized that mice deficient in PDC must increase the proportion of energy derived from acetate metabolism in the brain. Unexpectedly, the distribution of (13)C in glutamate and glutamine, a measure of the relative flux of acetate and glucose into the citric acid cycle, was not altered. The (13)C labeling pattern in glutamate differed significantly from glutamine, indicating preferential oxidation of [1,2-(13)C]acetate relative to [1,6-(13)C]glucose by a readily discernible metabolic domain of the brain of both normal and mutant mice, presumably glia. These findings illustrate that metabolic compartmentation is preserved in the PDC-deficient cerebral cortex, probably reflecting intact neuron-glia metabolic interactions, and that a reduction in brain PDC activity sufficient to induce cerebral dysgenesis during development does not appreciably disrupt energy metabolism in the mature brain.
Copyright © 2012. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22884585      PMCID: PMC3816779          DOI: 10.1016/j.neuint.2012.07.020

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  46 in total

Review 1.  Disorders of pyruvate carboxylase and the pyruvate dehydrogenase complex.

Authors:  B H Robinson; N MacKay; K Chun; M Ling
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

2.  Outcome of pyruvate dehydrogenase deficiency treated with ketogenic diets. Studies in patients with identical mutations.

Authors:  I D Wexler; S G Hemalatha; J McConnell; N R Buist; H H Dahl; S A Berry; S D Cederbaum; M S Patel; D S Kerr
Journal:  Neurology       Date:  1997-12       Impact factor: 9.910

3.  Trafficking of amino acids between neurons and glia in vivo. Effects of inhibition of glial metabolism by fluoroacetate.

Authors:  B Hassel; H Bachelard; P Jones; F Fonnum; U Sonnewald
Journal:  J Cereb Blood Flow Metab       Date:  1997-11       Impact factor: 6.200

4.  Approaches to studies on neuronal/glial relationships by 13C-MRS analysis.

Authors:  A Taylor; M McLean; P Morris; H Bachelard
Journal:  Dev Neurosci       Date:  1996       Impact factor: 2.984

5.  Expression of a variant form of the glutamate transporter GLT1 in neuronal cultures and in neurons and astrocytes in the rat brain.

Authors:  Weizhi Chen; Chiye Aoki; Veeravan Mahadomrongkul; Christian E Gruber; Guang Jian Wang; Rachel Blitzblau; Nina Irwin; Paul A Rosenberg
Journal:  J Neurosci       Date:  2002-03-15       Impact factor: 6.167

6.  NMR spectroscopic study of cell cultures of astrocytes and neurons exposed to hypoxia: compartmentation of astrocyte metabolism.

Authors:  U Sonnewald; T B Müller; N Westergaard; G Unsgård; S B Petersen; A Schousboe
Journal:  Neurochem Int       Date:  1994-05       Impact factor: 3.921

7.  In vivo injection of [1-13C]glucose and [1,2-13C]acetate combined with ex vivo 13C nuclear magnetic resonance spectroscopy: a novel approach to the study of middle cerebral artery occlusion in the rat.

Authors:  A Håberg; H Qu; O Haraldseth; G Unsgård; U Sonnewald
Journal:  J Cereb Blood Flow Metab       Date:  1998-11       Impact factor: 6.200

8.  Preferential utilization of acetate by astrocytes is attributable to transport.

Authors:  R A Waniewski; D L Martin
Journal:  J Neurosci       Date:  1998-07-15       Impact factor: 6.167

9.  Metabolic differences between primary cultures of astrocytes and neurons from cerebellum and cerebral cortex. Effects of fluorocitrate.

Authors:  B Hassel; N Westergaard; A Schousboe; F Fonnum
Journal:  Neurochem Res       Date:  1995-04       Impact factor: 3.996

10.  Cerebral dysgenesis and lactic acidemia: an MRI/MRS phenotype associated with pyruvate dehydrogenase deficiency.

Authors:  M I Shevell; P M Matthews; C R Scriver; R M Brown; L J Otero; M Legris; G K Brown; D L Arnold
Journal:  Pediatr Neurol       Date:  1994-10       Impact factor: 3.372

View more
  9 in total

1.  The ratio of acetate-to-glucose oxidation in astrocytes from a single 13C NMR spectrum of cerebral cortex.

Authors:  Isaac Marin-Valencia; M Ali Hooshyar; Kumar Pichumani; A Dean Sherry; Craig R Malloy
Journal:  J Neurochem       Date:  2014-10-14       Impact factor: 5.372

2.  Acetate is a bioenergetic substrate for human glioblastoma and brain metastases.

Authors:  Tomoyuki Mashimo; Kumar Pichumani; Vamsidhara Vemireddy; Kimmo J Hatanpaa; Dinesh Kumar Singh; Shyam Sirasanagandla; Suraj Nannepaga; Sara G Piccirillo; Zoltan Kovacs; Chan Foong; Zhiguang Huang; Samuel Barnett; Bruce E Mickey; Ralph J DeBerardinis; Benjamin P Tu; Elizabeth A Maher; Robert M Bachoo
Journal:  Cell       Date:  2014-12-18       Impact factor: 41.582

3.  Acetyl-CoA production from pyruvate is not necessary for preservation of myelin.

Authors:  Gustavo Della-Flora Nunes; Lauren Mueller; Nicholas Silvestri; Mulchand S Patel; Lawrence Wrabetz; M Laura Feltri; Yannick Poitelon
Journal:  Glia       Date:  2017-06-28       Impact factor: 7.452

4.  Heptanoate as a neural fuel: energetic and neurotransmitter precursors in normal and glucose transporter I-deficient (G1D) brain.

Authors:  Isaac Marin-Valencia; Levi B Good; Qian Ma; Craig R Malloy; Juan M Pascual
Journal:  J Cereb Blood Flow Metab       Date:  2012-10-17       Impact factor: 6.200

5.  Hepatic gluconeogenesis influences (13)C enrichment in lactate in human brain tumors during metabolism of [1,2-(13)C]acetate.

Authors:  Kumar Pichumani; Tomoyuki Mashimo; Vamsidhara Vemireddy; Zoltan Kovacs; James Ratnakar; Bruce Mickey; Craig R Malloy; Ralph J DeBerardinis; Robert M Bachoo; Elizabeth A Maher
Journal:  Neurochem Int       Date:  2016-03-26       Impact factor: 3.921

6.  Cerebral glucose metabolism in an immature rat model of pediatric traumatic brain injury.

Authors:  Courtney L Robertson; Manda Saraswati; Susanna Scafidi; Gary Fiskum; Paula Casey; Mary C McKenna
Journal:  J Neurotrauma       Date:  2013-12-03       Impact factor: 5.269

Review 7.  Glucose Transporter Type I Deficiency (G1D) at 25 (1990-2015): Presumptions, Facts, and the Lives of Persons With This Rare Disease.

Authors:  Juan M Pascual; Gabriel M Ronen
Journal:  Pediatr Neurol       Date:  2015-08-10       Impact factor: 3.372

Review 8.  Cerebral Gluconeogenesis and Diseases.

Authors:  James Yip; Xiaokun Geng; Jiamei Shen; Yuchuan Ding
Journal:  Front Pharmacol       Date:  2017-01-04       Impact factor: 5.810

9.  Magnetic resonance spectroscopy for the study of cns malignancies.

Authors:  Victor Ruiz-Rodado; Jeffery R Brender; Murali K Cherukuri; Mark R Gilbert; Mioara Larion
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2020-12-02       Impact factor: 9.795

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.